The effectiveness of feed additives in chronic kidney disease in cats

Author:

Fedotkina S. N.1,Shinkarenko A. N.1ORCID,Strusovskaya O. G.1

Affiliation:

1. Volgograd State Medical University

Abstract

Chronic kidney disease in cats is one of the most common diseases. The main direction of palliative therapy for chronic kidney disease  and  extending  the  survival  time  of cats  is  to  limit  phosphates  in  the  diet  and normalize the phosphorus content in the animal’s body. In order to reduce phosphates, phosphate  binders  are  used  -  substances whose mechanism of action is to bind excess phosphate  ions  in  the  gastrointestinal  tract, which  prevents  their  entry  into  the  blood-stream. The purpose of the study is to analyze  the  effectiveness  of  feed  additives “Urdetox” and “Ipakitine” in a comparative aspect in the palliative treatment of chronic kidney disease in cats. Determination of the biological activity of the proposed feed additive for cats with CKD in the form of tablets was  carried  out  on  the  basis  of  veterinary clinics in the city. Volgograd, St. Petersburg, Moscow, in the period 2021-2022. The objects  of  the  study  were  cats  whose  owners complained of loss of animal body weight, often  a  general  depressed  state,  decreased appetite,  periodic  vomiting,  frequent  urination, dull hair. The diagnosis and experiment were  carried  out  by  collecting  anamnestic data, determining clinical signs and laboratory data - a general urine test and a biochemical  analysis  of  blood  serum.  Studies  have shown that feed additives containing a phosphate binder and a detoxicant help eliminate the  main  clinical  manifestations  of  chronic renal failure. The introduction of the essential amino acid -taurine into the feed additive in the form of Urdetox tablets, as well as the accuracy of dosing and ease of use increase the effectiveness of its biological action.

Publisher

Saint-Petersburg State University of Veterinary Medicine

Subject

General Medicine

Reference9 articles.

1. Yerlepesova P. M., Maksudova M. H., Mukhiddinova N. Z. Studying the membrane-protective efficacy of taurine in clinical conditions //Biology and integrative medicine. - 2017. – No. 2. – pp. 34-41.

2. Koba, I. S., Lifentsova, M., Novikova, E. N., & Glushchenko, S. G. Analysis of manifestations of urolithiasis in cats // Polythematic online electronic scientific journal of the Kuban State Agrarian University. – 2018. – No. 135. pp. 1-11

3. Larionova O. S.] and others. The use of chitosan in the complex therapy of chronic renal failure in cats and dogs //Rabbit breeding and animal husbandry. – 2017. – №. 6. – Pp. 25-28.

4. Plavskikh O. V., Degtyareva E. O., Kopylovich M. V. The use of phosphate binders in chronic renal failure in cats // Actual problems of veterinary science and practice. – 2021. – pp. 166-169.

5. Ryadchikova O. L. Peculiarities of cats' nutritional needs //Polythematic online electronic scientific journal of the Kuban State Agrarian University. - 2020. – No. 163. – pp. 1-22.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3